
Matthias Paireder, MD
Department of General Surgery (Division of Visceral Surgery)
Position: Consultant
ORCID: 0000-0001-7119-8454
matthias.paireder@meduniwien.ac.at
Keywords
Barrett Esophagus; Esophageal Neoplasms; Oncology; Upper Gastrointestinal Tract
Research group(s)
Grants
- ACO ASSO Publication Award (2017)
Source of Funding: Austrian Society of Surgical Oncology, Award
Principal Investigator - Fellowship of Surgical Oncology (2014)
Source of Funding: Austrian Society of Surgical Oncology, Ingrid Shaker-Nessmann Cancer Research Association
Principal Investigator
Selected publications
- Paireder, M. et al., 2020. Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Strahlentherapie und Onkologie. Available at: http://dx.doi.org/10.1007/s00066-020-01594-z.
- Paireder, M. et al., 2019. Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility—a safety and efficacy study. Surgical Endoscopy, 33(11), pp.3623–3628. Available at: http://dx.doi.org/10.1007/s00464-018-06649-y.
- Paireder, M. et al., 2017. External validation of the NUn score for predicting anastomotic leakage after oesophageal resection. Scientific Reports, 7(1). Available at: http://dx.doi.org/10.1038/s41598-017-10084-9.
- Paireder, M. et al., 2017. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. European Journal of Surgical Oncology (EJSO), 43(2), pp.478–484. Available at: http://dx.doi.org/10.1016/j.ejso.2016.11.015.
- Paireder, M. et al., 2018. Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE). European Surgery, 50(6), pp.249–255. Available at: http://dx.doi.org/10.1007/s10353-018-0552-y.